| NIDA Home > About NIDA > Organization > DESPR | |
Division of Epidemiology, Services and Prevention Research (DESPR) |
|
Guidance for ApplicantsNIH Grant Application ProcessAll grants should be submitted according to the procedures described in the Federal Funding Opportunity Announcement (FOA) to which you are responding. Normally applications are submitted via electronic submission through Grants.gov using the Federal-wide Standard Form 424 - Research and Research Related (SF424 (R&R)). Applicants should take careful note of the submission schedule in each FOA as these dates are fluid. Paper applications will be accepted only for mechanisms when no electronic submission form or method (other than the SF 398) is specified. Applicants should always refer to the funding opportunity announcement (e.g., Program Announcement/PA or Request for Applications/RFA) to obtain guidance on applying and the correct forms to use. For research project grants using the R01, R03, and R21 mechanism, "Parent" (i.e., generic) PAs are published to offer guidance for applications not addressing a focused NIH priority. One-time registrations for both Grants.gov/GetStarted and eRA Commons systems must be completed by the applying organization before application submission. These are two distinct systems with separate registration requirements. Grant.gov
All grants should be submitted according to the procedures described in the Federal Funding Opportunity Announcement (FOA) to which you are responding. Normally applications are submitted via electronic submission through Grants.gov using the Federal-wide Standard Form 424 - Research and Research Related (SF424 (R&R)). Applicants should take careful note of the submission schedule in each FOA as these dates are fluid. Paper applications will be accepted only for mechanisms when no electronic submission form or method (other than the SF 398) is specified. FOLLOW ALL INSTRUCTIONS CAREFULLY! Each funding opportunity announcement (program announcement/request for application (PA/RFA)) includes an application package with an application guide (sample guide). This document is critical to submitting a complete and accurate application to NIH. There are fields within the SF424 (R&R) components that are not marked as mandatory on the federal-wide form but that are required by NIH. For example, the Credential field of the R&R Senior/Key Person Profile component must contain the PI's assigned eRA Commons User ID. Agency-specific instructions for such fields are clearly identified in the application guide. The FOA to which you are applying also may include guidance on application submission. Taking advantage of these resources will save you time in the long run by avoiding the need to correct errors and resubmit your application. GET INFORMED! NIH is using the Electronic Submission website, http://era.nih.gov/ElectronicReceipt/, as its primary tool for communications. The site is continually updated to provide you with the latest information and answers to your questions.
New InvestigatorsNIH is very welcoming of new investigators regardless of career stage. Applying to NIDA for an NIH grant can be a daunting and tortuous process even for experienced grant awardees. In 2008, NIH enhanced its commitment to advantage applications from new and early stage investigators (ESI). New PIs are those applicants who have not previously been awarded an R01 grant even though they may have had R03 or R21 awards as PIs. ESIs are defined as new investigators whose terminal research degree or medical residency was completed less than 10 years ago. ESI applications will be reviewed separately with new investigators. ESIs will enjoy an accelerated revision cycle. NIH summarizes its policies to support new and ESI applicants on its website. There are various special support resources available to ESI status applicants which can be found on a special new investigator website. In addition, The National Institute of Allergy and Infections Diseases provides comprehensive advice for investigators at any level. It is sufficiently generic to be useful in applying for grants in any NIH institute or center. Human Subjects Protection and Inclusion PoliciesNIH grantees must adhere to various policies intended to promote the ethical execution of research that supports the nations public health. Below are links to major information sources on the web that address human subjects and inclusion policies that affect grants typical of those in DESPR's portfolio.
Data and Safety Monitoring GuidanceNIH grantees must establish written guidance on procedures for ensuring the safety of participants in clinical research in order to avoid, detect, intercede, and remedy any harm that might occur incident to a research project.
Budget RegulationsNIH grantees must use public funds in an appropriate and ethical manner. There exist limits on principal investigator discretion, caps on amounts that can be spent for various purposes, and rules for the carry over of unspent funds to subsequent periods of research:
|
|
External link, please review our disclaimer here.
External link, please review our disclaimer here.
External link, please review our disclaimer here.


